Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BASF Acquires Z-COTE Micro Zinc Oxide Ingredient From SunSmart

This article was originally published in The Tan Sheet

Executive Summary

BASF's purchase of SunSmart's Z-COTE transparent zinc oxide formulation line provides the company with its first UVA sunscreen ingredient. The deal, which closed Nov. 30, includes Z-COTE microfine zinc oxide and Z-COTE HP1, a dimethicone hydrophobic coated form of the original.

You may also be interested in...



SPF testing an "accurate reflection" of ingredient photostability -- CTFA rep.

SUNSCREEN SPF TESTING ACCURATELY REFLECTS INGREDIENT PHOTOSTABILITY, CTFA said, noting photostability has been a concern raised often with the introduction of more technically advanced UVA sunscreen ingredients such as microfine zinc oxide, microfine titanium dioxide and avobenzone. James Johnson, PhD, University of Tennessee-Memphis College of Pharmacy, speaking on behalf of the Cosmetic, Toiletry & Fragrance Association at a June 3 FDA "feedback" meeting on sunscreens, maintained the current SPF testing method provides "an accurate reflection of the performance of the product."

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel